These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8571690)

  • 1. [Gestagens and hormone substitution].
    Klinger G
    Zentralbl Gynakol; 1995; 117 Suppl():25-9. PubMed ID: 8571690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which estrogens and gestagens should be prescribed after 45 years of age and for how long?].
    Göretzlehner G
    Zentralbl Gynakol; 1990; 112(13):793-4. PubMed ID: 2238980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for estrogen and progestin replacement therapy in climacteric and postmenopause. 31. Professional Meeting of the Zurich Discussion Circle, October 2003].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):258-64. PubMed ID: 15459525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gestagen supplementation to estrogen therapy in climacteric].
    Iversen OE
    Tidsskr Nor Laegeforen; 2001 Jan; 121(1):82-3. PubMed ID: 12013622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormone substitution in climacteric. Position of the German Menopause Society].
    Schneider HP; Kuhl H; Dören M; Hesch D
    Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gestagens and breast diseases].
    Lober R
    Zentralbl Gynakol; 1995; 117 Suppl():19-24. PubMed ID: 8571688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Substitution therapy with estrogens and gestagens].
    Kuhl H
    Dtsch Med Wochenschr; 1995 May; 120(21):765-8. PubMed ID: 7781501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormone substitution in menopause].
    Keller PJ; Maurer-Major E
    Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy: clinical benefits and side-effects.
    de Lignieres B
    Maturitas; 1996 May; 23 Suppl():S31-6. PubMed ID: 8865137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gestagens and corpus luteum insufficiency].
    Rothe K
    Zentralbl Gynakol; 1995; 117 Suppl():2-5. PubMed ID: 8571689
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of gestagens in prevention and therapy of endometrial hyperplasia].
    Römer T
    Zentralbl Gynakol; 1995; 117 Suppl():14-8. PubMed ID: 8571687
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause made easier.
    Crandall SG
    RN; 1997 Jul; 60(7):46-50; quiz 51. PubMed ID: 9256801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations of the study group "Hormone substitution in postmenopause after breast cancer" of the German Society for Breast Diseases].
    Maass H; Brändle LW; von Fournier D; Lauritzen C; Schulz KD
    Zentralbl Gynakol; 1990; 112(18):1169-70. PubMed ID: 2275292
    [No Abstract]   [Full Text] [Related]  

  • 18. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
    Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
    Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.